Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, ottobre 21
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Rigel Pharmaceuticals Inc
RIGL
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$48.11
1.39
2.98%
Ult. Agg.: Oct 20, 4:00 PM
$48.11
1.39
2.98%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Rigel Pharmaceuticals Analyst Price Targets - Benzinga
Rigel Pharmaceuticals Analyst Price Targets
Wall Street analyst price targets and consensus rating for Rigel Pharmaceuticals (RIGL).
Analyst Ratings News
PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $85 price target.
Benzinga Newsdesk
PRO
Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $49
Piper Sandler analyst Allison Bratzel maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price target from $40 to $49.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $85
HC Wainwright & Co. analyst Joseph Pantginis maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and raises the price target from $57 to $85.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $57 price target.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $57 price target.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $57 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $57 price target.
Benzinga Newsdesk
Crea una watchlist
GRATIS: Segui le azioni e criptovalute con le migliori notifiche di internet
Clicca per iniziare
People Also Watch
AbbVie Inc
NYSE:ABBV
$289.19
0.04%
Amgen Inc
NASDAQ:AMGN
$435.7
-0.74%
Gilead Sciences Inc
NASDAQ:GILD
$155.9
-0.39%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
$512.32
-0.45%
Moderna Inc
NASDAQ:MRNA
$241.8
-0.12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
$807.48
-%
Natera Inc
NASDAQ:NTRA
$408.75
0.7%
argenx SE
NASDAQ:ARGX
$869.72
-%
BeOne Medicines Ltd
NASDAQ:ONC
$384.5
-%
Revolution Medicines Inc
NASDAQ:RVMD
$196.69
0.07%
Mostra tutte le 10 aziende correlate
